<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-20T12:34:51Z</responseDate><request verb="GetRecord" identifier="oai:digital.lib.washington.edu:1773/48792" metadataPrefix="dim">https://digital.lib.washington.edu/server/oai/request</request><GetRecord><record><header><identifier>oai:digital.lib.washington.edu:1773/48792</identifier><datestamp>2026-06-11T20:10:46Z</datestamp><setSpec>com_1773_4888</setSpec><setSpec>col_1773_44474</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Ratner, Buddy D.</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author" authority="eb913ed7-d88e-420e-8b48-1d14e88e142f" confidence="300">Tang, Runbang</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2022-07-14T22:04:50Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2022-07-14</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="submitted">2022</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other">Tang_washington_0250E_24548.pdf</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/1773/48792</dim:field>
   <dim:field mdschema="dc" element="description">Thesis (Ph.D.)--University of Washington, 2022</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract">Traditional hemodialysis disturbs the personal lives of end-stage renal disease 
(ESRD) patients while providing poor outcomes (5-year survival rate &amp;lt;50%). Portable or 
wearable hemodialysis machines provide continuous hemodialysis similar to human 
kidneys, and have the potential to liberate ESRD patients and improve the treatment 
outcomes. However, a key challenge towards the development of portable dialysis devices 
is to decrease the consumption of the dialysate (120 L dialysate needed for one traditional 
hemodialysis session). This problem could be solved by removing specific toxins from 
used dialysate to achieve dialysate recycle, for which molecularly imprinted polymers 
(MIPs) and membranes are good candidate materials.  
This dissertation provides material solutions to enable dialysate purification in 
portable dialysis devices. In Chapter 2 of this dissertation, we developed MIPs for specific 
removal of trimethylamine nitro-oxide (TMAO) in pure water. We systematically 
optimized the performance of MIPs against functional monomers, monomer/crosslinker 
ratio, monomer additives, and template amount. We identified the best-performed MIPs to 
have the composition of MAA/EGDMA = 8:1, synthesized through thermal 
polymerization and purified by Soxhlet extraction. The developed MIPs can specifically 
bind to TMAO against structurally similar compounds (i.e., dimethyl sulfoxide (DMSO)) 
in pure water solutions, with a capacity of 1 mg/g. From isotherm characterization, we 
observed a 6.81mg/g maximum capacity of the MIPs, while the corresponding non
imprinted polymers only have a 0.28 mg/g maximum capacity, indicating the success of 
molecular imprinting. We evaluated the MIPs capacity under various flow conditions (1
20 mL/min) and observed a stable capacity of 1 mg/g towards TMAO. Based on this 
capacity, only 160 g MIPs are needed for one hemodialysis session, demonstrating enough 
capacity for portable dialysis machines. 
In Chapters 3 and 4 of this dissertation, we developed MIPs that can specifically 
remove indoxyl sulfate and p-cresol sulfate. In pure water, we developed the best
performed MIPs through a combination of three functional monomers with one crosslinker, 
dimethylaminoethyl methacrylamide (DMAEMA): hydroxyethyl methacrylate (HEMA) : 
styrene : ethylene glycol dimethacrylate (EGDMA) = 1:2:1:5, providing electrostatic 
interactions, hydrogen bonding and stacking interaction, respectively. The best MIPs 
showed a capacity of 3.3 mg/g with high capacity and specificity against two competing 
compounds (tryptophan and glutamic acid). In dialysate solution with physiologic ion 
strength, the optimal MIPs in pure water showed moderate capacity of 0.5mg/g. We further 
optimized the MIPs performance in dialysate by switching charged functional monomer 
from tertiary amine DMAEMA to primary amine (N-(3-aminopropyl) methacrylamide 
(APM), which improved the capacity to 2.5 mg/g in dialysate while sustaining the same 
specificity. APM potentially brought additional hydrogen bonds as well as electrostatic 
interaction to effectively remove indoxyl sulfate and p-cresol sulfate. 
Chapter 5 of this dissertation developed membranes to specifically separate glucose 
from urea in dialysate. We systematically studied the influence of polymer choice, polymer 
concentration, synthesis temperature, molecular imprint, additives, and solvent 
composition to the membrane’s permeability. We identified a cellulose acetate membrane, 
synthesized with 14 wt% of cellulose acetate in a mixture of solvents with 46 wt% dioxane, 
18 wt% acetone, 8 wt% acetic acid, and 14 wt% that were able to permeate urea while 
completely excluding glucose, which enabled the electro-oxidation of urea in portable 
dialysis machines. The cellulose acetate membranes showed a permeation ratio between 
urea and glucose ratio of &amp;gt;30. We further increased the flux of urea by 1.8×, while 
maintaining the exclusion of glucose for the membranes, via an optimized heat treatment 
temperature of 65°C. The optimized membranes showed a urea permeation coefficient of 
3.6 cm2/s. For 14 g of urea generated per day in the human body, only 6 h is required to 
permeate through 1m2 of the membrane. 
</dim:field>
   <dim:field mdschema="dc" element="format" qualifier="mimetype">application/pdf</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso">en_US</dim:field>
   <dim:field mdschema="dc" element="rights">CC BY</dim:field>
   <dim:field mdschema="dc" element="subject">cellulose acetate membrane</dim:field>
   <dim:field mdschema="dc" element="subject">indoxyl sulfate</dim:field>
   <dim:field mdschema="dc" element="subject">molecularly imprinted polymers</dim:field>
   <dim:field mdschema="dc" element="subject">p-cresol sulfate</dim:field>
   <dim:field mdschema="dc" element="subject">trimethylamine N-oxide</dim:field>
   <dim:field mdschema="dc" element="subject">Polymer chemistry</dim:field>
   <dim:field mdschema="dc" element="subject">Bioengineering</dim:field>
   <dim:field mdschema="dc" element="subject" qualifier="other">Molecular engineering</dim:field>
   <dim:field mdschema="dc" element="title">Uremic Toxins Removal in Kidney Dialysis through Molecularly Imprinted Polymers and Membranes</dim:field>
   <dim:field mdschema="dc" element="type">Thesis</dim:field>
   <dim:field mdschema="dc" element="embargo" qualifier="terms">Restrict to UW for 5 years -- then make Open Access</dim:field>
   <dim:field mdschema="dc" element="embargo" qualifier="lift">2027-06-18T22:04:50Z</dim:field>
   <dim:field mdschema="others" element="access-status">embargo</dim:field>
</dim:dim>
</metadata></record></GetRecord></OAI-PMH>